ANI PHARMACEUTICALS, INC Restricted Cash, Current
ANI PHARMACEUTICALS, INC (ANIP) had Restricted Cash, Current of $35.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-07
- 2026-06-30: Restricted Cash, Current $35.00K.
- 2026-03-31: Restricted Cash, Current $36.00K.
- 2025-12-31: Restricted Cash, Current $36.00K.
- 2025-09-30: Restricted Cash, Current $36.00K.
| Period end | Restricted Cash, Current | Restricted Cash, Current as first filed |
|---|---|---|
| 2026-06-30 | $35.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $36.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $36.00K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $36.00K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-07 | $36.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $34.00K 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $0.00 10-Q · filed 2026-08-07 | $33.00K 10-K · filed 2025-02-28 |
| 2024-09-30 | $35.00K 10-Q · filed 2025-11-07 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $5.01M 10-K · filed 2026-02-27 | |
| 2022-09-30 | $5.00M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $5.00M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $5.00M 10-Q · filed 2023-05-08 | |
| 2021-12-31 | $5.00M 10-K · filed 2025-02-28 | |
| 2020-12-31 | $5.00M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |